The OncoExTra assay identified both common and rare TERT promoter alterations, which are prognostic for cancer progression, including commonly occurring G-to-A substitutions occurring –124 and –146 bp relative to the TERT transcription start site known to drive increased telomerase expression [34, 72, 73]. Here, TERT is linked to cancer.